CHARLOTTE, N.C., April 04, 2018 -- Legacy Good Samaritan, a dedicated community leader and a medical center of national acclaim, has partnered with HIFU Prostate Services, LLC (HPS), to bring HIFU as a treatment option for localized prostate cancer to the Portland area. HPS is the leading provider of HIFU technology to physician practices in the United States.
“At Legacy Good Samaritan we are committed to making Portland a better, healthier place to live. We are proud to add HIFU to the list of procedures we offer for patients in our community because it offers men an outpatient, less invasive treatment option for prostate cancer,” said Jonathan Avery, President of Legacy Good Samaritan Medical Center.
HIFU uses focused ultrasound energy to rapidly heat and destroy tissue in the prostate. It is an accurate and precise procedure that eliminates prostatic tissue without damaging areas around the prostate. This greatly reduces the risk of side effects such as urinary incontinence and erectile dysfunction commonly seen with more invasive treatments.
Stanley Myers, MD, a urologist with Northwest Urology in Portland, treated the first patient at Legacy Good Samaritan this past week and is the most experienced HIFU physician in the pacific northwest. Dr. Myers has been using HIFU for nearly ten years to treat patients with prostate cancer.
"Thanks to the preparation, hard work, and attention to detail by the OR team, the procedure went extremely well,” said Dr. Myers. “The patient awoke with no pain and went home a few hours after the HIFU procedure.”
Last summer, a Medicare code was issued by the Centers for Medicare and Medicaid Services that may help some patients cover part of the cost of the HIFU procedure. Additional information about reimbursement may be found at https://www.hifuprostateservices.com/reimbursement.
“The number of hospitals and medical centers that offer HIFU in the US continues to grow which clearly exhibits the increasing adoption of HIFU as a treatment option for localized prostate cancer. We look forward to working with Legacy Good Samaritan to offer HIFU in their hospital,” said John Linn, chief executive officer, HIFU Prostate Services.
As a one-time, outpatient procedure, HIFU allows patients to return home the same day as their procedure and return to their normal lifestyle within a few days. HIFU may be repeated, if necessary, and can be used to treat patients that have failed radiation therapy.
About HIFU Prostate Services, LLC
HIFU Prostate Services was founded to provide access to a less invasive prostate cancer treatment option. It has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC and has locations in 14 cities throughout the US. Learn more at http://www.hifuprostateservices.com.
About Legacy Good Samaritan Medical Center
Located in the heart of Northwest Portland, Legacy Good Samaritan Medical Center was founded in 1875 by the Episcopal Diocese of Oregon. Today, “Good Sam” is a nationally acclaimed medical center that is home to much of Legacy Health’s highly specialized care. Good Sam is not only known for its renowned physicians and cutting-edge technology, it is also a dedicated community partner to the neighborhood it has called home for the past 140 years. From the strong partnerships with schools and faith-based organizations to the numerous wellness programs and health screenings offered throughout the year, Legacy Good Samaritan is committed to making Portland a better, healthier place to live.
Media Contact:
John Linn
(704) 248-7562
HIFU Prostate Services
Piseth Pich
(503) 413-7742
Legacy Good Samaritan Medical Center


Telegram Restored on Apple App Store After Temporary Removal
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 



